The Bioweapon Prevention Act of 2025 prohibits federal funding for any research center or laboratory in which a national of a designated 'country of concern' conducts agricultural research. The statute covers all federal monies and defines the covered states in a single definition section.
This is a narrow but blunt statutory tool: it links grant and contract eligibility directly to personnel presence rather than to conduct or intent. For research administrators and compliance officers at universities, USDA labs, and private agritech firms, the bill would create an immediate screening and eligibility problem for federally supported agricultural research programs.
At a Glance
What It Does
The bill makes federal funding unavailable to research centers or laboratories where nationals of specified foreign states conduct agricultural research. It accomplishes this by a single prohibition and a list-style definition of 'country of concern.'
Who It Affects
Land-grant universities, federal agricultural research labs, state extension services, private agritech research centers that accept federal grants or contracts, and foreign nationals participating in agricultural research programs. Federal agencies that award research funds would also face new compliance questions.
Why It Matters
The measure replaces case-by-case export-control or grant-terms decisions with a categorical eligibility cutoff tied to personnel presence. That raises immediate compliance, contracting, and international-collaboration issues for organizations that rely on federal research support.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill contains two operative elements: a blanket prohibition on federal funding to any research center or laboratory in which a national of a designated foreign state conducts agricultural research, and a follow-on definition that enumerates the covered states. Under the bill, the presence — not the activity's content or the individual's intent — triggers ineligibility: if a covered national conducts agricultural research at a facility, that facility ceases to be eligible for federal funds.
Because the statute attaches ineligibility to the location (a research center or laboratory) rather than to a specific grant, agencies will face implementation choices that the bill does not resolve. Agencies must decide whether to cut funding for particular projects housed in an affected facility, suspend entire center awards, or condition future awards on personnel changes.
Grant administrators will need to determine what it means to 'conduct agricultural research' (principal investigator role, lab technician duties, remote collaboration, subcontracted projects) and how to treat joint appointments and multi-institution consortia.The bill also delegates no explicit enforcement or waiver authority. That silence forces federal funders to interpret the prohibition within their existing administrative frameworks — for example, by adding new eligibility certifications, creating audit triggers, or applying debarment-like remedies on an ad hoc basis.
Compliance officers should anticipate increased personnel screening, new disclosure obligations on applicants, and potential legal exposure if an agency retroactively determines a facility violated the prohibition.
The Five Things You Need to Know
The statute prohibits any federal funding to a research center or laboratory in which a national of a 'country of concern' conducts agricultural research.
Section 2(b) names six 'countries of concern': Cuba; Iran; the Russian Federation; the People’s Republic of China (including Hong Kong and Macau); Venezuela; and North Korea.
The bill ties ineligibility to personnel presence — the phrase 'in which a national ... conducts agricultural research' — rather than to specific prohibited acts or intent.
The text contains no waiver, exception, or implementing agency assignment; it states the prohibition categorically and leaves enforcement and administration unspecified.
The bill uses the term 'national' rather than 'citizen,' which has a broader legal meaning and could affect how agencies determine covered individuals' status.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
This single-line provision supplies the Act's public name, 'Bioweapon Prevention Act of 2025.' Its practical effect is to label the statute for reference; it contains no operative rule or definitional material.
Categorical funding prohibition tied to personnel presence
This is the operative clause: 'No Federal funding shall be available to any research center or laboratory in which a national of a country of concern conducts agricultural research.' Read literally, agencies would have to withhold federal support from any facility meeting that condition. The clause does not specify whether the prohibition applies prospectively only or also allows agencies to claw back or terminate ongoing awards, nor does it define which types of federal funding (grants, cooperative agreements, contracts, intra-agency funds) fall within 'Federal funding.'
Enumerated definition of 'country of concern'
This subsection lists the six states that trigger the prohibition. Because the statute ties eligibility to named countries, its scope is entirely dependent on that list. The provision does not include a mechanism to add or remove states, leaving any future expansion or contraction to subsequent legislative action or judicial interpretation rather than administrative rulemaking.
This bill is one of many.
Codify tracks hundreds of bills on Agriculture across all five countries.
Explore Agriculture in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Federal national-security and agricultural biosecurity officials: they obtain a clear, statutory bar intended to reduce opportunities for hostile-state access to U.S. agricultural research infrastructure.
- Grant reviewers focused on sensitive projects: the categorical rule simplifies eligibility decisions for projects judged to pose elevated risks, removing the need for ad hoc case-by-case determinations.
- Institutions that already exclude personnel from listed states: these entities gain clearer eligibility advantages when competing for federal funds against centers that host nationals from the named countries.
Who Bears the Cost
- Universities and research centers with international staff or collaborative projects: they face new screening obligations, potential loss of grant funding if a covered national participates at a facility, and the administrative costs of restructuring projects or personnel.
- Federal agencies that award agricultural research funds: agencies must create compliance processes, interpret vague terms, and handle disputes without direction in the bill, imposing administrative burdens and potential litigation risk.
- Foreign nationals from the listed countries and their host institutions: researchers and visiting scholars may lose opportunities to work at federally funded sites or to participate in cooperative projects, affecting careers and institutional partnerships.
- Private agritech firms engaged in global hiring or partnerships: these firms risk ineligibility for federal programs if they host or subcontract to researchers from the listed states, complicating hiring and partnership strategies.
Key Issues
The Core Tension
The central dilemma is straightforward: the bill advances biosecurity by eliminating federal funding where specified foreign nationals participate in agricultural research, but that categorical approach undermines scientific openness, complicates international collaboration, and shifts large compliance and decision-making burdens onto agencies and institutions without offering tailored remedies or implementation guidance.
The bill's clarity about its objective contrasts with significant ambiguity about implementation. It does not define 'research center' or 'laboratory,' leaving agencies to decide whether a single PI's lab bench, a multi-building research park, or an entire university campus becomes ineligible if a covered national conducts agricultural research there.
The statute similarly leaves 'conducts agricultural research' undefined: does remote analysis of crop genomics from abroad count? Does a short-term collaborator or a subcontracted company trigger the ban?
These questions determine both the practical reach of the prohibition and the compliance burden on institutions.
The statute's use of the term 'national' and its enumerated country list create legal and operational points of tension. 'National' can be broader than 'citizen' in U.S. immigration and nationality law, complicating verification. The list-based approach gives the Congress direct control over scope but offers no built-in process for updating the list when geopolitical circumstances change.
Finally, the bill forces a trade-off between reducing perceived foreign access risks and preserving the workforce, capacity, and international collaboration that underpin U.S. agricultural R&D; the text contains no mitigation tools (waivers, phased compliance, or funding carve-outs) to smooth that transition.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.